Brookfield Renewable generated $1.3 billion in funds from operations (FFO) last year, or $2.01 per share. That's up 10% from 2024. The company benefited from the strong performance of its existing ...
The Chief Scientific Officer of this biopharmaceutical company sold 20,000 shares in mid-January 2026, amid the company's stock rising 71% throughout the month.
The chief medical officer at one of the top pharmaceutical companies sold nearly 10,000 shares in late January 2026, but the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results